Intravenous phenytoin is contraindicated in which of the following:
Phenytoin is licensed for tonic-clonic and focal seizures but may exacerbate absence or myoclonic seizures and should be avoided if these seizures are present. It is also used in status epilepticus refractory to benzodiazepines, given intravenously.
Carbamazepine, lamotrigine, valproate and phenytoin act by producing a use-dependent block of neuronal Na+ channels. Their anticonvulsant action is a result of their ability to prevent high-frequency repetitive activity. The drugs bind preferentially to inactivated (closed) Na+ channels, stabilising them in the inactivated state and preventing them from returning to the resting (closed) state, which they must re-enter before they can again open.
It has a narrow therapeutic index and the relationship between dose and plasma drug concentration is non-linear; small dosage increases in some patients may produce large increases in plasma concentration with acute toxic side-effects. Similarly, a few missed doses or a small change in drug absorption may result in a marked change in plasma-drug concentration. Monitoring of plasma drug concentration improves dosage adjustment; the usual total plasma-phenytoin concentration for optimum response is 10 – 20 mg/litre (or 40 – 80 micromol/ litre).
Phenytoin is contraindicated in acute porphyrias. Intravenous phenytoin is additionally contraindicated in second- and third-degree heart block, sinoatrial block, sinus bradycardia and Stokes-Adams syndrome.
Adverse effects include:
Symptoms of phenytoin toxicity include nystagmus, diplopia, slurred speech, ataxia, confusion, and hyperglycaemia.
Phenytoin is an enzyme-inducing drug and can accelerate the metabolism of certain drugs result in reduced therapeutic effect of that drug, such as corticosteroids, warfarin, doxycycline, oral contraceptive pill and thyroid hormones amongst others.
Is there something wrong with this question? Let us know and we’ll fix it as soon as possible.
Biochemistry | Normal Value |
---|---|
Sodium | 135 – 145 mmol/l |
Potassium | 3.0 – 4.5 mmol/l |
Urea | 2.5 – 7.5 mmol/l |
Glucose | 3.5 – 5.0 mmol/l |
Creatinine | 35 – 135 μmol/l |
Alanine Aminotransferase (ALT) | 5 – 35 U/l |
Gamma-glutamyl Transferase (GGT) | < 65 U/l |
Alkaline Phosphatase (ALP) | 30 – 135 U/l |
Aspartate Aminotransferase (AST) | < 40 U/l |
Total Protein | 60 – 80 g/l |
Albumin | 35 – 50 g/l |
Globulin | 2.4 – 3.5 g/dl |
Amylase | < 70 U/l |
Total Bilirubin | 3 – 17 μmol/l |
Calcium | 2.1 – 2.5 mmol/l |
Chloride | 95 – 105 mmol/l |
Phosphate | 0.8 – 1.4 mmol/l |
Haematology | Normal Value |
---|---|
Haemoglobin | 11.5 – 16.6 g/dl |
White Blood Cells | 4.0 – 11.0 x 109/l |
Platelets | 150 – 450 x 109/l |
MCV | 80 – 96 fl |
MCHC | 32 – 36 g/dl |
Neutrophils | 2.0 – 7.5 x 109/l |
Lymphocytes | 1.5 – 4.0 x 109/l |
Monocytes | 0.3 – 1.0 x 109/l |
Eosinophils | 0.1 – 0.5 x 109/l |
Basophils | < 0.2 x 109/l |
Reticulocytes | < 2% |
Haematocrit | 0.35 – 0.49 |
Red Cell Distribution Width | 11 – 15% |
Blood Gases | Normal Value |
---|---|
pH | 7.35 – 7.45 |
pO2 | 11 – 14 kPa |
pCO2 | 4.5 – 6.0 kPa |
Base Excess | -2 – +2 mmol/l |
Bicarbonate | 24 – 30 mmol/l |
Lactate | < 2 mmol/l |